Parasitic worms, or nematodes, cause a lot of trouble. They bring on various diseases in animals and even in humans. The drugs used to fight these pests, known as anthelmintics, are becoming less effective. This is due to the worms developing resistance to these treatments. So, finding new ways to tackle these worms is crucial.

A recent study focused on creating new compounds to combat these parasites. Thirteen new versions of a chemical called benzhydroxamic acid, named OMKs, were made. These were tested on two types of nematodes: Haemonchus contortus, which affects animals, and Caenorhabditis elegans, which lives freely in the environment. The goal was to see if these new compounds could kill the worms without harming mammals.

One of these compounds, OMK211, stood out. It was effective against both larval and adult stages of the nematodes. It worked well even against drug-resistant strains of Haemonchus contortus. The best results were seen in adult male Haemonchus contortus. Importantly, OMK211 did not show toxicity in mammalian cells or mice. This means it could be safe for use in animals.

To understand how OMK211 works, scientists used a method called thermal proteome profiling. They found that OMK211 interacts with a specific protein in Haemonchus contortus. This protein, encoded by the gene HCON_00184, 900, is a potential target for new drugs. It is present in many nematodes but not in mammals, making it a good target for selective treatment.

The study suggests that these new derivatives of benzhydroxamic acid could be a promising class of anthelmintics. They need more testing, but they show potential in fighting parasitic worms effectively and safely. This is a significant step forward in the battle against these harmful pests.

DRUG RESISTANCE IN NEMATODES

New Hope in the Fight Against Parasitic Worms

Continue reading...